We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Study Links Bypass Surgery to Cognitive Changes

By HospiMedica staff writers
Posted on 01 Aug 2002
Another study has found that coronary artery bypass grafting (CABG) may be associated with an increased risk of stroke, short-term memory problems, and long-term cognitive changes. More...
The results were presented at the 8th International Conference on Alzheimer's Disease and Related Disorders in Stockholm (Sweden).

Researchers collected data on 3,300 patients undergoing CABG between 1997 and 2001. They found that 2.6% of them suffered a stroke and 6.8% developed acute confusion or short-term memory problems. They also found that there is a 50% increase in the probability of acute confusion for each hour on the bypass pump. Changes in the cognitive function of the patients were monitored for one month, one year, and five years following surgery.

In the short term, cognitive changes involving memory and attention generally improved within one year of surgery. Between one and five years, however, the researchers identified cognitive declines, noting that patients with severe cerebrovascular disease at baseline were more likely to experience a delayed decline. Based on the study, risk factors for stroke and acute confusion following CABG have been developed.

"There appears to be a subpopulation of patients undergoing coronary bypass surgery with risk factors for cerebrovascular disease, who are at greater risk for stroke, cognitive decline, and long-term cognitive changes,” said Guy M. McKhann, M.D., professor of neurology at Johns Hopkins School of Medicine (Baltimore, MD, USA), who led the study.




Related Links:
Johns Hopkins

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.